Trigeminal Neuralgia
📧 Sign up to get email alerts when something new happens for Trigeminal Neuralgia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-06-13FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for carbamazepine from Sun Pharmaceutical Industries, Inc., indicating an update to the product's re…
-
FDA approval · 2013-06-13FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for carbamazepine submitted by Sun Pharmaceutical Industries, Inc.
-
CLINICAL_TRIALS trial_result · 2013-06-12Clinical Trial Update: IAN Injury After BSSO in Oral Clefts
A clinical trial update from Chang Gung Memorial Hospital concerns inferior alveolar nerve injury (a branch of the trigeminal nerve) after b…
-
FDA label_change · 2013-03-06FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Tegretol (carbamazepine) filed by Novartis Pharmaceuticals Corporation. The supplemental act…
-
FDA approval · 2013-03-06FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Tegretol (carbamazepine) submitted by Novartis Pharmaceuticals Corporation.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-12-27Clinical Trial Update: Surface Acoustic Wave Ultrasound in Trigeminal Neuralgia Pain [Phase 4]
A Phase 4 trial evaluating surface acoustic wave ultrasound for trigeminal neuralgia has completed.
-
FDA approval · 2012-11-13FDA Approved: EQUETRO — Supplemental Application (Validus Pharmaceuticals LLC)
The FDA approved a supplemental application for EQUETRO (carbamazepine) submitted by Validus Pharmaceuticals LLC.
-
FDA approval · 2012-07-19FDA Approved: EPITOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for EPITOL (carbamazepine) from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2012-06-19FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved a supplemental application for carbamazepine from Torrent Pharmaceuticals Limited. This represents a supplemental approval …
-
FDA approval · 2012-06-19FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Carbamazepine from Torrent Pharmaceuticals Limited.
-
CLINICAL_TRIALS withdrawal · 2012-04-30Clinical Trial Update: Transcranial Magnetic Stimulation (TMS) Effects on Pain Perception [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating transcranial magnetic stimulation for pain perception was withdrawn, with conditions including trigemi…
-
FDA approval · 2012-01-27FDA Approved: EQUETRO — Supplemental Application (Validus Pharmaceuticals LLC)
The FDA approved a supplemental application for EQUETRO (carbamazepine) submitted by Validus Pharmaceuticals LLC.
-
FDA approval · 2012-01-26FDA Approved: CARBAMAZEPINE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for the generic anticonvulsant carbamazepine from Chartwell RX, LLC.
-
FDA approval · 2012-01-24FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for carbamazepine submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2012-01-24FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for carbamazepine from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2011-10-30FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Tegretol (carbamazepine) submitted by Novartis Pharmaceuticals Corporation.
-
FDA approval · 2011-10-30FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Tegretol (carbamazepine) submitted by Novartis Pharmaceuticals Corporation.
-
FDA approval · 2011-09-27FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approves a supplemental application for Carbamazepine from Torrent Pharmaceuticals Limited.
-
FDA approval · 2011-08-22FDA Approved: CARBATROL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for CARBATROL (carbamazepine) filed by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2011-05-20FDA Approved: CARBAMAZEPINE — Original Application (ANI Pharmaceuticals, Inc.)
FDA approves ANI Pharmaceuticals' original application to market a generic carbamazepine formulation under an ANDA.
-
FDA approval · 2011-03-03FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Tegretol (carbamazepine) from Novartis Pharmaceuticals Corporation, authorizing changes to the p…
-
FDA approval · 2010-10-24FDA Approved: EQUETRO — Supplemental Application (Validus Pharmaceuticals LLC)
FDA approved a supplemental application for EQUETRO (carbamazepine) from Validus Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2010-06-29Clinical Trial Update: Efficacy and Safety Study of Lamotrigine to Treat Trigeminal Neuralgia [Phase 2, Phase 3]
A Phase 2/3 trial investigating the efficacy and safety of lamotrigine for trigeminal neuralgia has completed.
-
FDA approval · 2010-05-27FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Carbamazepine submitted by Torrent Pharmaceuticals Limited.
-
FDA approval · 2010-02-23FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries, Inc.'s supplemental application for carbamazepine (generic).